J. Banerji

发表

Impact of the malaria comprehensive case management programme in Odisha, India

K. Mendis, N. Valecha, S. Duparc, 2022, PloS one.

Closing the access barrier for effective anti-malarials in the private sector in rural Uganda: consortium for ACT private sector subsidy (CAPSS) pilot study

A. Talisuna, J. Tibenderana, G. Jagoe, 2012, Malaria Journal.

A comparison of alprazolam with amitriptyline in the treatment of patients with neurotic or reactive depression

J. Straková, A. Scott, J. Banerji, 1989, Irish journal of medical science.

Counterfeit antimalarial drugs.

J. Banerji, D. Reddy, 2012, The Lancet. Infectious diseases.

Cost is killing patients: subsidising effective antimalarials

P. Grewal, A. Talisuna, G. Jagoe, 2009, The Lancet.

Improved access to early diagnosis and complete treatment of malaria in Odisha, India

K. Mendis, N. Valecha, S. Duparc, 2019, PloS one.

Redoubling efforts to sustain seasonal malaria chemoprevention.

K. Malm, P. Olumese, S. Filler, 2022, The Lancet. Child & adolescent health.

Introducing field digital data collection systems into seasonal malaria chemoprevention campaigns: opportunities for robust evidence development and national e-health strategies

S. Oppong, K. Malm, J. Nikau, 2022, BMJ Global Health.

Comprehensive case management of malaria: Operational research informing policy

K. Mendis, S. Pradhan, N. Valecha, 2019, Journal of vector borne diseases.

Eliminating malaria in southeast Asia requires more attention on adolescent girls.

C. Menéndez, R. González, J. Banerji, 2021, The Lancet. Child & adolescent health.

Cost is killing patients: subsidising effective antimalarials

P. Grewal, A. Talisuna, G. Jagoe, 2009, The Lancet.